
CJC-1295 Dac 10mg
$78.00
CJC-1295 DAC is a long-acting synthetic analog of Growth Hormone Releasing Hormone (GHRH) designed to stimulate the body's natural production and release of growth hormone. Through the incorporation of Drug Affinity Complex (DAC) technology, CJC-1295 DAC exhibits an extended duration of activity, making it a valuable research tool for investigating growth hormone physiology, endocrine regulation, and age-related metabolic processes.
By selectively binding to GHRH receptors within the anterior pituitary gland, CJC-1295 DAC promotes the natural pulsatile secretion of growth hormone while preserving the body's endogenous regulatory mechanisms. This targeted approach has generated significant interest among researchers seeking to better understand the relationship between growth hormone signaling, metabolic health, body composition, recovery, and healthy aging.
Preclinical and clinical investigations have demonstrated that CJC-1295 DAC can significantly elevate circulating growth hormone and insulin-like growth factor-1 (IGF-1) levels over extended periods. These effects have made the peptide an important model compound for studying the downstream biological pathways involved in protein synthesis, tissue repair, cellular regeneration, energy metabolism, and physiological adaptation.
Researchers have explored CJC-1295 DAC in a wide range of applications related to body composition, musculoskeletal health, exercise recovery, metabolic efficiency, and endocrine function. Its prolonged activity profile provides a unique opportunity to examine the long-term effects of enhanced growth hormone signaling while maintaining a more physiologically relevant pattern of hormone release compared to direct growth hormone administration.
As interest in peptide-based approaches to metabolic optimization and longevity science continues to expand, CJC-1295 DAC remains a cornerstone compound in growth hormone research. Its innovative design and extended receptor activity have established it as a valuable tool for advancing the understanding of endocrine regulation, cellular recovery, and the biological mechanisms that support healthy aging and overall physiological resilience.
CAS NO: 863288-34-0
Molecular Formula: C152H252N44O42
Molecular Weight: 3367.954 g/mol
Appearance: White Powder
Research Use Only
This product is intended solely for in vitro laboratory research purposes. It is not approved for human or animal use and must not be used in food, dietary supplements, pharmaceuticals, or cosmetic applications. All products arrive in lyophilized (freeze-dried) powder form.
Legal Disclaimer
This product and any associated information have not been evaluated by the U.S. Food and Drug Administration (FDA). No representations or warranties are made regarding its use for the diagnosis, treatment, cure, or prevention of any disease. Use is strictly limited to qualified professionals operating in properly equipped and certified laboratory environments.
Terms of Sale
By purchasing from Cutting Edge Compounds, the buyer certifies that they are a qualified researcher or represent a licensed institution. The buyer assumes full responsibility for ensuring compliance with all applicable laws and regulations governing the purchase, handling, storage, and use of this product. All sales are final.
STRENGHT | BATCH/LOT | RECEIVED | PURITY (%) | COA |
10mg | CEC-CJC-10-01 | April 2026 | 99.6% |
|---|
This product is intended solely for in vitro laboratory research purposes. It is not approved for human or animal use and must not be used in food, dietary supplements, pharmaceuticals, or cosmetic applications. All products arrive in lyophilized (freeze-dried) powder form.
Cutting Edge Compounds
We take pride in delivering high-quality research products you can trust. All of our products are made using premium-grade ingredients and undergo rigorous testing to ensure purity, potency, and consistency.
Contact
Helpful links
support@cuttingedgecompounds.com
MAILING ADDRESS
19510 Van Buren Blvd #F3-292
Riverside, Ca 92508


Please note that all products featured on this website are intended strictly for research and development purposes only. They are not designed for human consumption. The statements made on this website have not been evaluated by the U.S. Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease. Cutting Edge Compounds operates solely as a chemical supplier. We are not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor are we an outsourcing facility as defined under Section 503B of the same act.
©2024 Cutting Edge Compounds · All Rights Reserved
